Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|September 18, 2018
Actions of the National Regulatory Authorities in 10 Low- and Middle-Income Countries Following Stringent Regulatory Authority Safety Alerts on RosiglitazoneJude Nwokike, Lassane Kabore, Andy Stergachis
Current Opinion in HIV and AIDS|May 26, 2012
Pharmacovigilance and global HIV/AIDSVeronica Miller, Jude Nwokike, Andy Stergachis
Plos One|October 6, 2021
A descriptive study of healthcare-providers' experiences with the use and quality of oxytocin for the prevention of post-partum hemorrhage in Nigeria: A nation-wide surveyChioma S Ejekam, Florence M Nyangara, Chimezie Anyakora, et al.
Trials|April 13, 2019
Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trialsYorokpa Joachim Doua, Hanneke Dominicus, Julius Mugwagwa, et al.
Plos One|July 8, 2025
A comparative analysis of three pharmacovigilance system assessment toolsMuhammad Akhtar Abbas Khan, Jude Nwokike, Asim Rauf, et al.
BMC Pregnancy and Childbirth|June 2, 2024
Patterns of oxytocin use for induction and augmentation of labour among healthcare providers in NigeriaChioma S Ejekam, Ifeoma P Okafor, Kehinde S Okunade, et al.
Malaria Journal|June 1, 2010
A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposalsAndy Stergachis, Rebecca J K Bartlein, Alexander Dodoo, et al.
BMC Health Services Research|September 20, 2017
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturerChimezie Anyakora, Obinna Ekwunife, Faith Alozie, et al.
Frontiers in Medicine|March 12, 2026
The World Health Organization Coalition of Interested Parties Network: a unified and coordinated approach to regulatory system strengtheningAndrea Keyter, Tariro Sithole, Alireza Khadem Broojerdi, et al.
Drug Safety|February 20, 2014
A framework for assessing the economic value of pharmacovigilance in low- and middle-income countriesJoseph B Babigumira, Andy Stergachis, Hye Lyn Choi, et al.
Pageof 2